CSIMarket
 
Abbott Laboratories  (ABT)
Other Ticker:  
 
 

Abbott Laboratories Income Statement Quarterly

ABT


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 9,964.00 10,143.00 9,978.00 9,747.00
Revenue From Contract With Customer Excluding Assessed Tax - - - -
Total Revenue 9,964.00 10,241.00 10,143.00 9,978.00 9,747.00
Cost of Goods and Services Sold 4,463.00 4,556.00 4,605.00 4,483.00 4,331.00
Gross Profit 5,501.00 5,685.00 5,538.00 5,495.00 5,416.00
Selling, Administration, Marketing 2,959.00 2,724.00 2,723.00 2,740.00 2,762.00
Depriciation & Amortization 472.00 481.00 496.00 498.00 491.00
Research and Development Expense 684.00 700.00 672.00 715.00 654.00
Restructuring charges - - - - -
Other exp. /-income - - - - -
Special Items - - - - -
Total operating costs including COS 8,578.00 8,461.00 8,496.00 8,436.00 8,238.00
Operating income/-loss 1,386.00 1,780.00 1,647.00 1,542.00 1,509.00
Other Deductions / - Income
Interest expense 141.00 159.00 166.00 159.00 153.00
Interest income - - - - -
Net interest expense/-income 141.00 159.00 166.00 159.00 153.00
Investment Income, Interest - - - - -
Foreign Currency Transaction Gain (Loss), before Tax - 24.00 -10.00 21.00 6.00
Sale of Assets - - - - -
Financing Loss/ -Income - - - - -
Other loss/ -income -191.00 -198.00 -180.00 -274.00 -212.00
Total costs & expenses 8,528.00 8,446.00 8,472.00 8,342.00 8,185.00
Income /-loss before income taxes 1,436.00 1,795.00 1,671.00 1,636.00 1,562.00
Income taxes expenses/-benefit 211.00 201.00 235.00 261.00 244.00
Income after income taxes 1,225.00 1,594.00 1,436.00 1,375.00 1,318.00
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. 1,225.00 1,594.00 1,436.00 1,375.00 1,318.00
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 1,225.00 1,594.00 1,436.00 1,375.00 1,318.00
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 1,225.00 1,594.00 1,436.00 1,375.00 1,318.00
EBIT 1,577.00 1,954.00 1,837.00 1,795.00 1,715.00
EBITD 1,910.00 2,286.00 2,165.00 2,097.00 2,030.00
EBITDA 2,382.00 2,767.00 2,661.00 2,595.00 2,521.00


Per Share (GAAP Quarterly, in $) (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Basic EPS (excl. extra items) 0.70 0.92 0.82 0.79 0.75
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 0.70 0.92 0.82 0.79 0.75
Basic shares outstanding (Mill. of Units) 1,740.20 1,739.20 1,738.70 1,740.36 1,741.74
   EPS other shares - - - - -
Diluted Net EPS 0.70 0.92 0.82 0.78 0.75
Diluted average shares (Mill. of Units) 1,749.65 1,755.52 1,748.29 1,750.25 1,751.72
Dividend per share 0.547 0.506 0.508 0.508 0.508



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com